Longevity is still a relatively young industry, and its growth depends on collaboration rather than competition. In this field, funds with the capacity to evaluate a wide range of startups and projects have a responsibility to share knowledge, collaborate with co-investors, and offer insights from due diligence to accelerate the pace of innovation.
LongeVC’s Sergey Jakimov recently discussed these ideas on the Levity Podcast with hosts Peter Ottsjö and Ingemar Patrick Linden. He shared how LongeVC takes a collaborative approach to investment, emphasising the importance of building a network of partners who can collectively support groundbreaking work in longevity. Sergey also spoke about the need for solutions that make complex science more accessible, as well as his thoughts on how optimism plays a crucial role in driving change in this sector.
It was an insightful conversation, shedding light on how LongeVC’s portfolio companies, such as Rubedo, Ani Biome, and Turn Bio, are contributing to the future of healthcare and longevity.
You can check out the full episode on YouTube, Spotify and Apple Podcasts.
LongeVC’s Sergey Jakimov recently discussed these ideas on the Levity Podcast with hosts Peter Ottsjö and Ingemar Patrick Linden. He shared how LongeVC takes a collaborative approach to investment, emphasising the importance of building a network of partners who can collectively support groundbreaking work in longevity. Sergey also spoke about the need for solutions that make complex science more accessible, as well as his thoughts on how optimism plays a crucial role in driving change in this sector.
It was an insightful conversation, shedding light on how LongeVC’s portfolio companies, such as Rubedo, Ani Biome, and Turn Bio, are contributing to the future of healthcare and longevity.
You can check out the full episode on YouTube, Spotify and Apple Podcasts.